360 related articles for article (PubMed ID: 26965286)
1. A novel gene expression signature for bone metastasis in breast carcinomas.
Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
[TBL] [Abstract][Full Text] [Related]
2. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior.
Savci-Heijink CD; Halfwerk H; Hooijer GKJ; Koster J; Horlings HM; Meijer SL; van de Vijver MJ
Breast Cancer Res Treat; 2019 Apr; 174(3):649-659. PubMed ID: 30610490
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of metastatic behaviour of breast cancer subtypes.
Savci-Heijink CD; Halfwerk H; Hooijer GK; Horlings HM; Wesseling J; van de Vijver MJ
Breast Cancer Res Treat; 2015 Apr; 150(3):547-57. PubMed ID: 25820592
[TBL] [Abstract][Full Text] [Related]
6. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
Lawler K; Papouli E; Naceur-Lombardelli C; Mera A; Ougham K; Tutt A; Kimbung S; Hedenfalk I; Zhan J; Zhang H; Buus R; Dowsett M; Ng T; Pinder SE; Parker P; Holmberg L; Gillett CE; Grigoriadis A; Purushotham A
Breast Cancer Res; 2017 Oct; 19(1):113. PubMed ID: 29029636
[TBL] [Abstract][Full Text] [Related]
7. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.
Brockton NT; Gill SJ; Laborge SL; Paterson AH; Cook LS; Vogel HJ; Shemanko CS; Hanley DA; Magliocco AM; Friedenreich CM
BMC Cancer; 2015 Jul; 15():512. PubMed ID: 26156521
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
Kimbung S; Johansson I; Danielsson A; Veerla S; Egyhazi Brage S; Frostvik Stolt M; Skoog L; Carlsson L; Einbeigi Z; Lidbrink E; Linderholm B; Loman N; Malmström PO; Söderberg M; Walz TM; Fernö M; Hatschek T; Hedenfalk I;
Clin Cancer Res; 2016 Jan; 22(1):146-57. PubMed ID: 26276891
[TBL] [Abstract][Full Text] [Related]
9. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
11. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
12. Identification of estrogen-responsive genes involved in breast cancer metastases to the bone.
Wang J; Jarrett J; Huang CC; Satcher RL; Levenson AS
Clin Exp Metastasis; 2007; 24(6):411-22. PubMed ID: 17593529
[TBL] [Abstract][Full Text] [Related]
13. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
[TBL] [Abstract][Full Text] [Related]
14. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
16. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
18. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.
Marsan M; Van den Eynden G; Limame R; Neven P; Hauspy J; Van Dam PA; Vergote I; Dirix LY; Vermeulen PB; Van Laere SJ
PLoS One; 2014; 9(2):e89262. PubMed ID: 24586640
[TBL] [Abstract][Full Text] [Related]
19. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.
Nuyten DS; Hastie T; Chi JT; Chang HY; van de Vijver MJ
Eur J Cancer; 2008 Oct; 44(15):2319-29. PubMed ID: 18715778
[TBL] [Abstract][Full Text] [Related]
20. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
